PRKAA2 and endothelial dysfunction: A recent study also indicated that metformin, an AMPK activator, increases endothelial guanosine triphosphate cyclohydrolase, the rate-limiting enzyme in tetrahydrobiopterin (an essential cofactor for eNOS), resulting in improved endothelial dysfunction in DN26.